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Abstract
Objectives The objectives of this study were to estimate the prevalence of feline haemoplasma infections in Northern 
Serbia, identify potential risk factors and perform molecular subtyping of feline immunodeficiency virus (FIV).
Methods PCR analysis for feline haemoplasmas was performed on surplus EDTA blood samples from 373 cats 
from the Belgrade region, Serbia. An ELISA was used to determine the prevalence of feline leukaemia virus (FeLV) 
and FIV; PCR was performed on a subpopulation of these cats. FIV subtyping was performed using PCR.
Results Within this population, 64/373 cats (17.2%) were infected with one or more haemoplasma species. 
Mycoplasma haemofelis was detected in 20/373 cats (5.4%), ‘Candidatus Mycoplasma haemominutum’ in 
47/373 cats (12.6%) and ‘Candidatus Mycoplasma turicensis’ in 23/373 cats (6.2%). Coinfections were observed 
in 21/373 cats (5.6%). Based on ELISA serological retroviral testing, 4/310 cats (1.3%) were infected with FeLV, 
whereas 78/331 (23.6%) were infected with FIV. Multivariable analysis identified significant associations between 
haemoplasma infection and anaemia (anaemic/non-anaemic, odds ratio [OR] 2.7, 95% confidence interval [CI] 
1.04–7.1; P = 0.041]), male gender (male/female, OR 4.5, 95% CI 2.22–9.03; P <0.0005), outdoor access (yes/no, 
OR 5.2, 95% CI 2.28–11.92; P <0.0005), non-pedigree breed (non-pedigree/pedigree, OR 5.5, 95% CI 1.24–24.84; 
P = 0.025) and FIV seropositive status (positive/negative, OR 2.4, 95% CI 1.21–4.83; P = 0.012). PCR analysis of 
the FIV ELISA-positive samples revealed clade D as being the most prevalent.
Conclusions and relevance All three known species of feline haemoplasma were detected, confirming their 
presence in Serbia; ‘Candidatus Mycoplasma haemominutum’ was the most prevalent. We found a high prevalence 
of FIV-infected cats and FIV clade D was most prevalent.
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Introduction
Haemotropic mycoplasmas (haemoplasmas) are small, 
unculturable cell-wall-free bacteria that attach to the red 
blood cell surface of many domestic and wild animal 
species, and humans.1 Three feline haemoplasma species 
have been described so far: Mycoplasma haemofelis (Mhf) 
‘Candidatus Mycoplasma haemominutum’ (CMhm) and 
‘Candidatus Mycoplasma turicensis’ (CMt).
Mhf is the most pathogenic of the three haemoplasma 
species and acute infection often results in haemolytic 
anaemia, although some prevalence studies failed to 
show an association between Mhf and anaemia.2,3 Most 
infections with CMhm and CMt are not associated with 
anaemia or other clinical abnormalities, although they 
may play a pathogenic role in cats with concurrent dis-
ease, in particular coinfection with retroviruses, or 
immunosuppression.4,5
The natural route of transmission of the feline haemo-
plasmas has not yet been determined. It has been sug-
gested that horizontal transmission through arthropod 
vectors,6,7 aggressive interaction with blood transmis-
sion such as during cat bites8,9 and blood transfusions,3 
as well as vertical transmission from queen to kittens,10,11 
may play a role, but further studies are required.
There have been several studies investigating the 
prevalence of feline haemoplasmas, as well as potential 
risk factors for infection, in various countries world-
wide. Such studies have added relevance since the 
development of PCR assays, which are considered the 
diagnostic method of choice. Studies performed across 
Europe among healthy and unhealthy cats have identi-
fied prevalence rates ranging from 12–43.4%.2,12–20
The aims of this study were to: (1) determine the prev-
alence of Mhf, CMhm and CMt infections using PCR in 
cats from Serbia; (2) investigate potential associations 
between feline haemoplasma infections and risk factors 
such as sex, age, indoor/outdoor status, presence of 
ectoparasites, season, health status, anaemia and retrovi-
ral infections; (3) determine the prevalence of feline 
immunodeficiency virus (FIV) and feline leukaemia 
virus (FeLV) using ELISAs in cats from Serbia, followed 
by PCR in selected cases, as noted below; and to (4) iden-
tify the different clades of FIV present in Serbian cats 
using PCR.
Materials and methods
Case material
Blood samples were collected from 373 cats living in 
Belgrade and the surrounding wider region of Northern 
Serbia (Vojvodina). The cats were presented to various 
veterinary clinics between February 2011 and November 
2012, and the samples were obtained either from cats 
that were described as sick based on the presence of clin-
ical signs (eg, vomiting, hyporexia/anorexia, dyspnoea, 
oral lesions and dysuria, among others), or from cats 
described as clinically healthy, mostly presenting for a 
pre-anaesthetic screen or health check-up, as determined 
by the veterinarian that collected the blood samples. For 
each cat, information regarding breed, sex, age, weight, 
outdoor/indoor status and presence of ectoparasites 
was recorded.
Blood (0.5 ml) was collected from all cats into EDTA 
tubes for haematological analysis and real-time quantita-
tive (q)PCR testing. An additional 0.2–0.5 ml of blood was 
placed into plain tubes for serological testing.
Haematological analysis was performed within 1 h of 
blood collection using one of three different automated 
analysers (Abacus Junior Vet [Vetlab Supplies], AcT Diff 
[Beckman Coulter], Sysmex XS–500i [Sysmex ]), depend-
ing on the practice where the cats were seen. Cats with 
haemoglobin concentrations <80 g/l were diagnosed as 
anaemic.
Surplus whole blood and serum samples were stored 
at –20ºC before being transported on dry ice to the 
Diagnostic Laboratories, Langford Vets, University of 
Bristol, UK, for molecular and serological testing.
Haemoplasma qPCR assays
The DNA was extracted from 100 μl EDTA blood using a 
commercial kit and following the manufacturer’s 
instructions (Macherey–Nagel Nucleospin Blood Kit).
The DNA was eluted with 100 μl BE elution buffer 
provided with the kit and stored at –20°C prior to analy-
sis. Real-time qPCR assays were performed for Mhf, 
CMhm and CMt as described previously.21
An internal control assay (feline 28S rRNA gene) was 
run in multiplex with each haemoplasma species assay 
to confirm the presence of amplifiable DNA in each sam-
ple and a threshold cycle (Ct) cut-off value of <30 was 
used to indicate adequate amplifiable DNA. Positive 
controls (species-specific DNA from known haemo-
plasma-positive cats) and a negative control (water) 
were included in each qPCR.
FIV/FeLV ELISA and PCR assays
Serological testing for FIV (ELISA; PetChek FIV Antibody 
Test [IDEXX]) and FeLV (ELISA; PetChek FeLV Antigen 
Test [IDEXX]) was performed on available sera for the 
detection of specific antibodies to FIV gag (p24) and or/
env (gp40) and p27 FeLV antigen, following the manu-
facturer’s instructions.
For the FIV/FeLV PCR assays the extracted nucleic 
acid samples described above were used. The PCR tests 
for FeLV and/ or FIV were performed on all cats that 
tested positive by ELISA and from those that were not 
tested owing to insufficient or unavailable serum sam-
ples. The FeLV provirus qPCR analysis was performed 
as described previously,22 and positive (DNA from 
known FeLV-positive cats) and negative (water) controls 
were included in each qPCR.
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For the FIV PCR assay the extracted nucleic acid sam-
ples were first transported on dry ice to the IDEXX labo-
ratory in Ludwigsburg (Germany) for synthesis of 
cDNA. Then the cDNA was transported to the IDEXX 
laboratory in Sacramento (CA, USA) for FIV PCR testing 
using a commercially available assay (FIV RealPCR; 
IDEXX). The latter is a PCR (and reverse-transcriptase 
PCR) assay for detection of FIV provirus and virus tar-
geting a conserved region of the gag gene, while FIV 
clade was determined in infected cats using clade- 
specific primer pairs for clades A, B, C, D and F23,24 
(reported sensitivity and specificity for FIV RealPCRTM 
is 94% and 94% respectively).23,54
Statistical analysis
Data were recorded into Microsoft Office Excel 2007 
and then imported into SPSS (IBM) for statistical analy-
sis. Descriptive statistics were obtained for the continu-
ous variables (age, haemoglobin) and the following 
categorical variables: presence or absence of anaemia, 
sex, outdoor access, breed (pedigree/non-pedigree), 
presence of ectoparasites, health status (healthy/ill, 
defined by a veterinarian at presentation as specified 
above), season of sampling, as well as FeLV and FIV 
ELISA serology status. For assessment of seasonal vari-
ation, the months were grouped as follows: December, 
January and February (winter); March, April and May 
(spring); June, July and August (summer); September, 
October and November (autumn). The association of 
haemoplasma status and categorical variables was 
examined by univariate analysis using the Pearson χ2 
test or Fisher’s exact test. Odds ratios (OR) for predic-
tor variables and haemoplasma-positive status were 
also calculated. For the continuous variables, after 
assessing for normality of distribution (using a 
Kolmogorov–Smirnov test), their association to haemo-
plasma status (positive/negative) was examined using 
a Student’s t-test for normally distributed data and the 
Mann–Whitney U-test for non-normally distributed 
data. Binary logistic regression was performed to adjust 
for confounding factors for the outcome. Variables with 
P values <0.2 on the univariable analysis were consid-
ered to have a trend towards significance and were 
included in the multivariable model. Associations were 
considered statistically significant when P <0.05.
Results
Cats
Samples from 373 cats were collected and included in the 
study. The age of the cats ranged from 2 months to 22 
years (median 4 years). Male and female cats represented 
44.2% (n = 165/373) and 55.8% (n = 208/373) of the pop-
ulation, respectively. The number of non-pedigree cats 
(n = 280/373; 75.1%) was higher than that of pedigree 
cats (n = 93/373; 24.9%). Information regarding outdoor 
access was available for 372 cats of which 182 (48.9%) 
had outdoor access and 190 (51.1%) did not. The pres-
ence or absence of ectoparasites was specified in the 
records of 368 cats of which 79 (21.5%) stated the pres-
ence of ectoparasites. Information regarding health sta-
tus was available for 372 cats of which 107 (28.8%) were 
classified as ill and 265 (71.2%) as healthy. Of the 373 
cats, 37 were defined as anaemic (9.9%) and 336 as non-
anaemic (90.1%). Eighty-one cats (21.7%) were sampled 
in the summer, 77 (20.6%) in the autumn, 27 (7.2%) in the 
winter and 188 (50.4%) in the spring.
Haemoplasma qPCR results
All of the DNA extraction and qPCR-positive and nega-
tive controls performed, as well as the internal control 
qPCRs, were appropriately positive (with adequate 
DNA amounts for the internal control) or negative. Sixty-
four of the 373 cats (17.2%) were positive for one or more 
feline haemoplasma species; Mhf was detected in 20 
(5.4%), CMhm in 47 (12.6%) and CMt in 23 (6.2%) cats. 
Coinfections were identified in 21 cats (5.6%) (Table 1).
Table 1 Real-time quantitative PCR (qPCR) results for feline haemoplasma infection in 373 cats from Serbia
qPCR result (n = 373) Number of infected cats %
Any haemoplasma positive 64 17.2
Mhf positive 20 5.4
CMhm positive 47 12.6
CMt positive 23 6.2
Mhf positive only 3 0.8
CMhm positive only 31 8.3
CMt positive only 9 2.4
Mhf and CMhm dual positive 7 1.9
Mhf and CMt dual positive 5 1.3
CMhm and CMt dual positive 4 1.1
CMhm, Mhf and CMt triple positive 5 1.3
Mhf = Mycoplasma haemofelis; CMhm = ‘Candidatus Mycoplasma haemominutum’, CMt = ‘Candidatus Mycoplasma turicensis’
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FIV and FeLV ELISA and PCR results
The ELISA for FIV was performed on samples from 
331/373 cats as sera were not available for the remaining 
42 cats. When the available serum was adequate to per-
form only a single ELISA test, FIV ELISA was prioritised 
over FeLV ELISA. Seventy-eight (23.6%) of these 331 cats 
were FIV antibody positive on ELISA. In total, samples 
from 120 cats (78 that tested FIV antibody positive on 
ELISA and 42 for which sera were not available) were 
tested for FIV proviral DNA; 36 of these tested positive 
(25 were FIV antibody positive on ELISA and 11 had 
unknown FIV antibody status on ELISA). Subsequent 
clade designation of the 36 FIV PCR-positive cats identi-
fied 24 to be infected with clade D (66.7%), nine with 
clade F (25%), one with clade A (2.8%), one with clade B 
(2.8%) and one with a clade for which designation was 
not possible (2.8%).
For FeLV, ELISA was performed on samples from 
310/373 cats, as sera were not available for the remaining 
63 cats. Four of the 310 cats (1.3%) were FeLV p27 antigen 
ELISA-positive. FeLV PCR analysis was performed on 67 
samples (four were FeLV ELISA p27 positive and 63 had 
unknown FeLV ELISA p27 status), of which eight (11.9%) 
tested FeLV provirus positive (one was FeLV ELISA p27 
positive and seven had unknown FeLV ELISA p27 status).
Statistical analysis
Univariable analysis revealed P values of <0.2 for all 
nine categorical variables (Table 2) and the two continu-
ous variables (Table 3) with any haemoplasma species 
Table 2 Univariable relationships between categorical variables and any haemoplasma species-positive status in cats 
from Serbia; real-time quantitative PCR testing*
PCR  
Variable Negative
(% of total)
Positive
(% of total)
OR 95% CI P value
(Pearson χ2 or 
Fisher’s exact test†)
Anaemia (n = 373)  
 Anaemic 25/373 (6.7) 12/373 (3.2) 2.60 1.24–5.54 0.009‡
 Non-anaemic 284/373 (76.1) 52/373 (13.9)  
Sex (n = 373)  
 Male 122/373 (32.7) 42/373 (11.3) 2.90 1.66–5.14 <0.0005
 Female 187/373 (50.1) 22/373 (5.9)  
Outdoor access (n = 372)  
 Yes 132/372 (35.5) 50/372 (13.4) 5.16 2.69–9.88 <0.0005
 No 177/372 (47.6) 13/372 (3.5)  
Breed (n = 373)  
 Non-pedigree 218/373 (58.4) 62/373 (16.6) 12.94 3.10–54.0 <0.0005
 Pedigree 91/373 (24.4) 2/373 (0.5)  
Presence of ectoparasites (n = 368)  
 Yes 61/368 (16.6) 18/368 (4.9) 1.64 0.89–3.04 0.112
 No 245/368 (66.6) 44/368 (12.0)  
Health status (n = 372)  
 Ill 80/372 (21.5) 27/372 (7.3) 2.08 1.19–3.36 0.009
 Healthy 228/372 (61.3) 37/372 (9.9)  
Season (n = 373) 0.038
 Summer (June–August) 61/373 (16.4) 20/373 (5.4) 1.85 1.02–3.36 0.042
 Autumn (September–November) 70/373 (18.8) 7/373 (1.9) 0.42 1.03–1.23 0.035
 Winter (December–February) 20/373 (5.4) 7/373 (1.9) 1.78 0.72–4.39 0.210
 Spring (March–May) 158/373 (42.4) 30/373 (8.0) 0.843 0.49–1.45 0.535
FeLV status (ELISA) (n = 310)  
 Positive 2/310 (0.6) 2/310 (0.6) 5.25 0.72–38.13 0.128
 Negative 257/310 (82.9) 49/310 (15.8)  
FIV status (ELISA) (n = 331)  
 Positive 54/331 (16.3) 24/331 (7.3) 3.18 1.73–5.86 <0.0005
 Negative 222/331 (67.1) 31/331 (9.4)  
*Any haemoplasma species-positive status indicates positivity in at least one of the following haemoplasma PCRs: Mycoplasma haemofelis, 
‘Candidatus Mycoplasma haemominutum’, ‘Candidatus Mycoplasma turicensis’
†Fisher’s exact test used when one or more expected cell frequencies were <5
‡Variables with a P value of <0.05 are shown in bold
OR = odds ratio; CI in = confidence interval; FeLV = feline leukaemia virus; FIV = feline immunodeficiency virus
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(AHS)-positive status, which was defined as positivity 
in at least one of the three haemoplasma qPCRs: Mhf, 
CMhm and CMt. Significant associations (P <0.05), and 
thus significant risk factors, were identified between 
AHS-positive status and seven categorical variables. 
Five of these seven variables maintained significance 
following multivariable analysis: anaemia, male sex, 
outdoor access, non-pedigree breed and FIV ELISA-
positive status (Table 4). Associations with the remain-
ing two categorical variables (presence of ectoparasites 
and FeLV serology status) were not found to be signifi-
cant with AHS-positive status. Of the two continuous 
variables (age and haemoglobin), age was not found to 
be significantly associated with AHS-positive status. 
For haemoglobin, a statistically significant association 
for AHS-positive status was not found either, despite 
the above reported association found with anaemia; 
however, this had a trend towards significance.
A similar statistical analysis was also performed for 
the cats infected only with CMhm (n = 31), as this num-
ber of animals was considered adequate for statistical 
analysis. Such analysis was not possible for the cats posi-
tive only for Mhf (n = 3) or CMt (n = 9) as the number of 
infected animals was low. Univariable analysis revealed 
P values of <0.2 for 7/11 variables (Tables 5 and 6) with 
PCR positivity only for CMhm. Significant associations 
(P <0.05), and thus significant risk factors, were identi-
fied between CMhm only infection and five categorical 
variables and older age. Following multivariable analy-
sis, three variables maintained significance: outdoor 
access, FIV ELISA-positive status and older age (Table 7).
Univariable analysis revealed significant associations 
between AHS infection and anaemia, as well as dual or 
triple haemoplasma coinfections and anaemia (Table 8).
Discussion
To the best of our knowledge, this is the first study to 
investigate the prevalence of haemoplasmas in cats in 
Serbia and identify the different FIV clades in the feline 
population of this country. The amplification of haemo-
plasma DNA from the population sampled confirms the 
presence of all three known haemoplasma species, as 
well as coinfections with two or three of these species. 
Haemoplasma infection was present in both healthy and 
ill cats within the population studied.
Some of the characteristics of the cats in our popula-
tion, such as age, sex and breed, were similar to those in 
other published European studies,2,13,15 although direct 
comparisons are difficult.
Overall, the prevalence of feline haemoplasma infec-
tions found in this study was not substantially different 
to other European studies.2,12–18,20,25
CMhm was the most prevalent haemoplasma species 
(12.6%) in the Serbian cat population, similar to other 
reports in Europe (range 9.5–41.6%).2,12–15,17,20,25,26 Most 
previous studies reported CMt as the least prevalent 
feline haemoplasma species,13,16,17,20,25 but in the current 
study the prevalence of CMt infection was greater than 
that of Mhf.
The final multivariable logistic regression model for 
AHS infection revealed that male, non-pedigree cats 
that had outdoor access and that were anaemic or FIV 
Table 3 Univariable relationships between continuous variables and any haemoplasma species (AHS)-positive status in 
cats from Serbia*
Variable AHS-positive status (%) Median Minimum–maximum P value
Age (years) Positive 64/373 (17.1)
Negative 309/373 (82.8)
5
4
1–16
0.17–20
0.053
Haemoglobin (g/l) Positive 64/373 (17.1)
Negative 309/373 (82.8)
108.2
113.6
37–167
33–170
0.162
*Any haemoplasma species-positive status indicates positivity in at least one of the following haemoplasma PCRs: Mycoplasma haemofelis, 
‘Candidatus Mycoplasma haemominutum’ and ‘Candidatus Mycoplasma turicensis’
Table 4 Final significant multivariable relationships between predictor variables and any haemoplasma species-positive 
status in cats from Serbia*
Variable Adjusted OR 95% CI for OR P value
Anaemia (anaemic vs non-anaemic) 2.72 1.04–7.10 0.041
Sex (male vs female) 4.48 2.22–9.03 <0.0005
Outdoor access (yes vs no) 5.22 2.28–11.92 <0.0005
Breed (non-pedigree vs pedigree) 5.55 1.24–24.81 0.025
FIV ELISA status (positive vs negative) 2.42 1.21–4.83 0.012
*Any haemoplasma species-positive status indicates positivity in at least one of the following haemoplasma qPCRs; Mycoplasma haemofelis, 
‘Candidatus Mycoplasma haemominutum’ and ‘Candidatus Mycoplasma turicensis’
OR = odds ratio; CI = confidence interval; FIV = feline immunodeficiency virus
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Table 5 Univariable relationships between categorical variables and only ‘Candidatus Mycoplasma haemominutum’ 
species-positive status in cats from Serbia
qPCR  
Variable Negative
(% of total)
Positive
(% of total)
OR 95% CI P value
(Pearson χ2 test or 
Fisher’s exact test*)
Anaemia (n = 373)  
 Anaemic 33/373 (8.8) 4/373 (1.1) 1.39 0.46–4.21 0.531*
 Non-anaemic 309/373 (82.8) 27/373 (7.2)  
Gender (n = 373)  
 Male 146/373 (39.1) 18/373 (4.8) 1.86 0.88–3.91 0.099
 Female 196/373 (52.5) 13/373 (3.5)  
Outdoor exposure (n = 372)  
 Yes 159/372 (42.7) 23/372 (6.2) 3.29 1.43–7.56 0.003†
 No 182/372 (48.9) 8/373 (2.1)  
Breed (n = 373)  
 Non-pedigree 250/373 (67.0) 30/373 (8.0) 11.04 1.48–82.12 0.004
 Pedigree 92/373 (24.7) 1/373 (0.3)  
Presence of ectoparasites (n = 368)  
 Yes 74/368 (20.1) 5/368 (1.4) 0.68 0.25–1.84 0.449
 No 263/368 (71.5) 26/368 (7.1)  
Health status (n = 372)  
 Ill 92/372 (24.7) 15/372 (4.0) 2.54 1.21–5.34 0.012
 Healthy 249/372 (66.9) 16/372 (4.3)  
Season (n = 373) 0.049
 Summer (June–August) 71/373 (19.0) 10/373 (2.7) 1.82 0.82–4.03 0.137
 Autumn (September–November) 74/373 (19.8) 3/373 (0.8) 0.39 0.12–1.31 0.115
 Winter (December–February) 22/373 (5.9) 5/373 (1.3) 2.80 0.98–7.99 0.061*
 Spring (March–May) 175/373 (46.9) 13/373 (3.5) 0.69 0.33–1.45 0.325
FeLV status (ELISA) (n = 310)  
 Positive 3/310 (1.0) 1/310 (0.3) 4.10 0.41–41.02 0.277*
 Negative 283/310 (91.3) 23/310 (7.4)  
FIV status (ELISA) (n = 331)  
 Positive 62/331 (18.7) 16/331 (4.8) 5.68 2.51–12.85 <0.0005
 Negative 242/331 (73.1) 11/331 (3.3)  
*Fisher’s exact test used when one or more expected cell frequencies were <5
†Variables with a P value <0.05 are shown in bold
qPCR = quantitative PCR; OR = odds ratio; CI = confidence interval; FeLV = feline leukaemia virus; FIV = feline immunodeficiency
Table 6 Univariable relationships between continuous variables and only ‘Candidatus Mycoplasma haemominutum’ 
(CMhm) species-positive status in cats from Serbia
Variable Only CMhm species qPCR-positive 
status (%)
Median Minimum–maximum P value
Age (years) Positive 31/373 (8.3)
Negative 342/373 (91.7)
6.5
4
2–16
0.17–20
0.002*
Haemoglobin
(g/l)
Positive 31/373 (8.3)
Negative 342/373 (91.7)
110.7
112.9
64–160
33–170
0.647
*Variables with a P value of <0.05 are shown in bold
qPCR = quantitative PCR
ELISA- positive were more likely to be infected with 
AHS. Furthermore, outdoor access, positive FIV ELISA 
and age were identified as risk factors for cats infected 
with only CMhm.
The increased likelihood of male cats being infected 
with AHS over female cats has been frequently reported 
in other studies.2,3,27–29 Similarly, non-pedigree status 
and outdoor access are also commonly identified as risks 
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factors,2,3,29,30 which is in agreement with our findings. 
The higher prevalence of haemoplasmosis in male, non- 
pedigree cats with outdoor access supports the suggestion 
of transmission through aggressive interactions,8 as these 
cats are more likely to be involved in fighting and biting. 
The concurrent association with FIV seropositivity further 
supports this, as FIV is mostly transmitted through bites 
from persistently infected cats,31 and it is possible that 
these two infectious diseases are transmitted concurrently 
or through similar routes. Furthermore, FIV infection may 
play a role in haemoplasma infection owing to its immu-
nosuppressive effects.32
We identified that the cats infected only with CMhm 
were significantly older (median 6.5 years) than those 
that were not (median 4 years), which is in agreement 
with previous studies,2,26 possibly owing to the increased 
likelihood of exposure to the organism with age,2 and 
also the fact that CMhm is not reliably eliminated after 
infection.33–35
In our study an association between anaemia and AHS 
infection was identified (P = 0.041) on multivariable analysis, 
with haemoplasma coinfections being significantly (P 
<0.0005) associated with anaemia using univariable anal-
ysis. No significance was identified between anaemia and 
single infections with any of the haemoplasma species. 
Although some studies have similarly reported an asso-
ciation between anaemia and haemoplasma infection,36,37 
often this is not demonstrated.15,28,38,39 For Mhf and CMt 
this may be somewhat affected by the low numbers of 
cats that had infection with only one of these species. 
Furthermore, it has been suggested that anaemia is 
induced mainly in acute Mhf infections,3,4 and clinical 
signs may not be present in chronically infected animals. 
In the infected cats comprising our study population, the 
stage of infection was not known, but it is possible that 
these were chronically infected with Mhf. For CMhm 
and CMt it is generally acknowledged that these are 
often detected in non-anaemic cats.4 However, it is pos-
sible that in our population coinfections with two or 
three haemoplasma species played a role in the develop-
ment of anaemia, as has been previously suggested.40
Associations between haemoplasma infection and 
FIV,13,15,25,38,39,41–43 or, less commonly, FeLV,26,42 have 
been identified in several studies suggesting that cats 
infected with these retroviruses are at an increased risk 
for haemoplasma infection. However, another study 
did not identify retroviral-positive status as a risk fac-
tor.3 It is considered that the immunosuppressive effect 
of retroviruses is likely the cause of this association, 
although the possible common route of infection may 
also play a role. This study demonstrated a significant 
association of haemoplasma infection with FIV ELISA 
positivity, but not with FeLV. It is possible that the very 
low number of FeLV-positive cats in this population 
affected the outcome.
To the best of our knowledge this is the first study 
to generate information regarding the FIV clades in 
Serbia using PCR assays. In our population a high 
Table 7 Final significant multivariable relationships between predictor variables and only ‘Candidatus Mycoplasma 
haemominutum’ (CMhm) species quantitative PCR-positive status in cats from Serbia
Variable Adjusted OR 95% CI P value
Outdoor access (yes vs no) 5.54 1.84–16.70 0.002
FIV ELISA status (positive vs negative) 3.98 1.67–9.47 0.002
Age (years)* 1.19 1.08–1.33 0.001
*Odds ratio (OR) for a 1 year increase in age
CI = confidence interval; FIV = feline immunodeficiency virus
Table 8 Univariable relationships between anaemia and various haemoplasma species quantitative PCR-positive status 
in cats from Serbia
P value
(Pearson χ2 test or Fisher’s exact test*)
Any haemoplasma species positive† 0.009‡
Only Mhf positive 1*
Only CMhm positive 0.562
Only CMt positive 0.608*
Haemoplasma coinfections (dual or triple) <0.0005
*Fisher’s exact test used when one or more expected cell frequencies were <5
†Any haemoplasma species-positive status indicates positivity in at least one of the following haemoplasma PCRs: Mycoplasma haemofelis 
(Mhf), ‘Candidatus Mycoplasma haemominutum’ (CMhm) and ‘Candidatus Mycoplasma turicensis’ (CMt)
‡Variables with a P value <0.05 are shown in bold
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seroprevalence of FIV-infected cats was identified (23.6% 
[n = 78/331] on ELISA) and on the provirus PCR tested 
samples 30% (n = 36/120) were positive, whereas FeLV 
seroprevalence was found to be low (1.3% [n = 4/310]). 
A 2014 study on cats also from the Northern region of 
Serbia (from the area of Belgrade, and also of Novi Sad in 
Vojvodina, covering regions similar to this study) identi-
fied similar FIV (22%; n = 13/60) and FeLV (0/60 cats) 
prevalence using the rapid test SNAP Combo.44 It is 
interesting that clade D was prevalent in our study pop-
ulation, as clade D FIV viruses seem to have arisen from 
Japan.31,45,46 The so-far described worldwide distribution 
of FIV suggests that clades A, B and C are present in the 
USA,47 whereas in Europe clades A and B virus isolates 
are mainly found.48 Clade A is more common in Northern 
European countries, whereas in Southern and Central 
Europe clade B is the most frequently reported FIV 
clade;49 in our population clade B was found in one cat 
only. This could reflect that in the Balkan region FIV 
clades vary significantly compared with central Europe, 
but further studies in other Balkan countries are needed 
to establish this.
The FIV qPCR assays used at Diagnostic Laboratories, 
Langford Vets, are designed to detect clade A isolates, 
which is the predominant clade reported in the UK,50 so 
PCR analyses of the Serbian samples were performed at 
IDEXX where the qPCRs employed can detect other FIV 
clades. We acknowledge that there were discrepancies 
between the PCR- and ELISA-positive samples for both FIV 
and FeLV. Only 25/78 FIV ELISA-positive samples were 
found to be positive for FIV provirus on PCR analysis, 
which may reflect false positive results on ELISA, which 
have been previously reported with similar ELISA 
tests;23,51 the presence of other cross-reacting antibodies 
in the sample serum has been suggested as one possible 
explanation.51,52 Furthermore, in our study population, 
of the 78 cats that tested positive for FIV on ELISA, six 
were aged 6 months or younger, so it is possible that 
some of these tested positive as a result of the detection 
of passively acquired maternal antibodies. However, it is 
also likely that some of the samples were false negatives 
on the FIV provirus PCR. This is because, unfortunately, 
owing to an issue with the courier, the samples sent from 
the UK arrived in Germany thawed following a very 
long transit time, and this is likely to have caused degra-
dation of sample nucleic acid, thus resulting in false neg-
atives among the FIV PCR results. Furthermore, levels of 
proviral DNA and viral RNA may have been below the 
limit of detection,23,24,53 or a cat may have been infected 
with a clade of FIV not detected by the PCR assay.24,53  
It is worth mentioning here that vaccination against FIV 
is not performed in Serbia and none of these cats were 
vaccinated against FIV.
Potential explanations for the discordant results for 
FeLV (three ELISA-positive but PCR-negative) are that 
these were falsely positive by ELISA, as has been previ-
ously reported with this and other similar tests that 
detect the FeLV p27 antigen tests,54,55 or that these were 
false negative PCR results.22
In conclusion, regarding the discrepancies in retrovi-
ral testing, we acknowledge that not all results are avail-
able for all the cats in our study as PCR and ELISA 
testing were performed on different but overlapping 
subpopulations of these, which limits interpretation of 
the available results. These tests detect different aspects 
of infection and thus these discrepancies may be genu-
ine; however, the tests may also have inherent flaws, 
resulting in false positives and false negatives, which 
may confound the interpretation of the results.
Furthermore, as the presence of false negative FIV 
and FeLV ELISA results among the samples tested can-
not be excluded, and given the lack of molecular data on 
the seronegative samples, the prevalence of these retro-
viral infections may be underestimated.
As a further consideration, we appreciate that we did 
not differentiate between chronic and acute haemo-
plasma infections and the significance of the seasonal 
data reported may not always be relevant, in particular 
in the chronically infected cats, as the time of sampling is 
unlikely to reflect the time of infection in these. However, 
as this has been previously investigated in similar stud-
ies,13,29 this is still considered to be an interesting point 
and may contribute to further understanding of this 
disease.
We acknowledge that the present study utilised a con-
venience sample of cats. The limitations of such samples 
have been previously described,56 and it is likely that 
these results may not be truly representative of the gen-
eral prevalence of feline haemoplasma infection in 
Serbia. Furthermore, it is unfortunate that owing to 
insufficient funds and/or sample volume we were una-
ble to perform PCR and serology on all samples for the 
retroviruses. The described problems during shipping of 
the samples for FIV PCR analysis may also have affected 
our results regarding the prevalence of FIV and its asso-
ciation with haemoplasma infection.
Conclusions
Feline haemoplasmas were present in a population of 
Serbian cats and all three known species were detected, 
with CMhm being the most prevalent; the potential risk 
factors identified were mostly in accordance with other 
similar studies. Furthermore, we reported a high preva-
lence of FIV infection in cats from Serbia, and, interest-
ingly, identified clade D to be the most prevalent clade, 
whereas FeLV infection was found to be much less 
prevalent.
Author’s Note Séverine Tasker is also affiliated to Bristol 
Veterinary School, University of Bristol, Langford, UK.
Sarvani et al 9
Acknowledgements For collecting some of the study sam-
ples, the authors would like to thank Dr Milan Bisanić, DVM, 
and the following private veterinary practices: Dr Doolittle, 
Intervet, Petlife and Novak. Also, we would like to thank Ms 
Bistra Litajkovska for providing technical assistance. We would 
further like to thank Toby Knowles from School of Veterinary 
Sciences, University of Bristol, for assisting with the statistical 
analysis.
Conflict of interest The authors declared no potential con-
flicts of interest with respect to the research, authorship, and/
or publication of this article.
Funding The author(s) disclosed receipt of the following 
financial support for the research, authorship, and/or publica-
tion of this article: The study was funded by the Serbian Min-
istry for Education, Science and Technological Development, 
grant number 175061 (authors MKF, JFA and NA).
ORCID iD Charalampos Attipa  https://orcid.org/0000-
0001-6039-6586
References
 1 Sykes JE, Lindsay LL, Maggi RG, et al. Human coinfec-
tion with Bartonella henselae and two hemotropic myco-
plasma variants resembling Mycoplasma ovis. J Clin 
Microbiol 2010; 48: 3782–3785.
 2 Tasker S, Binns SH, Day MJ, et al. Use of a PCR assay to 
assess the prevalence and risk factors for Mycoplasma 
haemofelis and ‘Candidatus Mycoplasma haemominu-
tum’ in cats in the United Kingdom. Vet Rec 2003; 152: 
193–198.
 3 Willi B, Boretti FS, Baumgartner C, et al. Prevalence, risk 
factor analysis, and follow-up of infections caused by 
three feline hemoplasma species in cats in Switzerland. 
J Clin Microbiol 2006; 44: 961–969.
 4 Sykes JE. Feline hemotropic mycoplasmas. Vet Clin North 
Am Small Anim Pract 2010; 40: 1157–1170.
 5 George JW, Rideout BA, Griffey SM, et al. Effect of pre-
existing FeLV infection or FeLV and feline immunode-
ficiency virus coinfection on pathogenicity of the small 
variant of Haemobartonella felis in cats. Am J Vet Res 2002; 
63: 1172–1178.
 6 Willi B, Boretti FS, Meli ML, et al. Real-time PCR investiga-
tion of potential vectors, reservoirs and shedding patterns 
of feline hemotropic mycoplasmas. Appl Environ Microbiol 
2007; 73: 3798–3802.
 7 Barrs VR, Beatty JA, Wilson BJ, et al. Prevalence of Bar-
tonella species, Rickettsia felis, haemoplasmas and the 
Ehrlichia group in the blood of cats and fleas in eastern 
Australia. Aust Vet J 2010; 88: 160–165.
 8 Museux K, Boretti FS, Willi B, et al. In vivo transmission 
studies of ‘Candidatus Mycoplasma turicensis’ in the 
domestic cat. Vet Res 2009; 40: 45.
 9 Dean RS, Helps CR, Gruffydd-Jones T, et al. Use of real-
time PCR to detect Mycoplasma haemofelis and Candi-
datus Mycoplasma haemominutum’ in the saliva and 
salivary glands of haemoplasma-infected cats. J Feline Med 
Surg 2008; 10: 413–417.
 10 Harvey JW and Gaskin JM. Experimental feline haemobar-
tonellosis. J Am Anim Hosp Assoc 1977; 13: 28–38.
 11 Fisher EW, Toth S and Collier WO. Anaemia in a litter of 
Siamese kittens. J Small Anim Pract 1983; 24: 214–219.
 12 Spada E, Proverbio D, Galluzzo P, et al. Prevalence of hae-
moplasma infections in stray cats in northern Italy. ISRN 
Microbiol 2014; 2014: 298352.
 13 Gentilini F, Novacco M, Turba ME, et al. Use of combined 
conventional and real-time PCR to determine the epide-
miology of feline haemoplasma infections in northern 
Italy. J Feline Med Surg 2009; 11: 277–285.
 14 Maher IE, Tasker S, Polizopoulou Z, et al. Polymerase 
chain reaction survey of feline haemoplasma infections 
in Greece. J Feline Med Surg 2010; 12: 601–605.
 15 Martinez-Diaz VL, Silvestre-Ferreira AC, Vilhena H, et al. 
Prevalence and co-infection of haemotropic mycoplasmas 
in Portuguese cats by real-time polymerase chain reac-
tion. J Feline Med Surg 2013; 15: 879–885.
 16 Duarte A, Marques V, Correia JH, et al. Molecular detection 
of haemotropic Mycoplasma species in urban and rural 
cats from Portugal. J Feline Med Surg 2014; 17: 516–522.
 17 Laberke S, Just F, Pfister K, et al. Prevalence of feline 
haemoplasma infection in cats in Southern Bavaria, 
Germany, and infection risk factor analysis. Berl Munch 
Tierarztl Wochenschr 2010; 123: 42–48.
 18 Silaghi C, Knaus M, Rapti D, et al. Survey of Toxoplasma 
gondii and Neospora caninum, haemotropic mycoplasmas 
and other arthropod-borne pathogens in cats from Alba-
nia. Parasit Vectors 2014; 7: 62.
 19 Attipa C, Papasouliotis K, Solano-Gallego L, et al. Preva-
lence study and risk factor analysis of selected bacterial, 
protozoal and viral, including vector-borne, pathogens in 
cats from Cyprus. Parasit Vectors 2017; 10: 130.
 20 Roura X, Peters IR, Altet L, et al. Prevalence of hemotropic 
mycoplasmas in healthy and unhealthy cats and dogs in 
Spain. J Vet Diagn Invest 2010; 22: 270–274.
 21 Peters IR, Helps CR, Willi B, et al. The prevalence of three 
species of feline haemoplasmas in samples submitted 
to a diagnostics service as determined by three novel 
real-time duplex PCR assays. Vet Microbiol 2008; 126: 
142–150.
 22 Pinches MD, Helps CR, Gruffydd-Jones TJ, et al. Diagnosis 
of feline leukaemia virus infection by semi-quantitative 
real-time polymerase chain reaction. J Feline Med Surg 
2007; 9: 8–13.
 23 Westman ME, Malik R, Hall E, et al. Determining the feline 
immunodeficiency virus (FIV) status of FIV-vaccinated cats 
using point-of-care antibody kits. Comp Immunol Microbiol 
Infect Dis 2015; 42: 43–52.
 24 IDEXX Laboratories, Inc. IDEXX Reference Laboratories 
Introduces a RealPCR Test for Feline Immonodeficiency 
Virus (FIV). http://www.idexx.co.uk/pdf/en_gb/smallanimal/ 
education/realpcr-test-for-fiv.pdf (2009, accessed April 13, 2018).
 25 Attipa C, Papasouliotis K, Solano-Gallego L, et al. Preva-
lence study and risk factor analysis of selected bacterial, 
protozoal and viral, including vector-borne, pathogens in 
cats from Cyprus. Parasit Vectors 2017; 10: 130.
 26 Bauer N, Balzer HJ, Thure S, et al. Prevalence of feline hae-
motropic mycoplasmas in convenience samples of cats in 
Germany. J Feline Med Surg 2008; 10: 252–258.
10 Journal of Feline Medicine and Surgery Open Reports 
 27 Hayes HM and Priester WA. Feline infectious anaemia. 
Risk by age, sex and breed; prior disease; seasonal occur-
rence; mortality. J Small Anim Pract 1973; 14: 797–804.
 28 Aquino LC, Hicks CA, Scalon MC, et al. Prevalence and 
phylogenetic analysis of haemoplasmas from cats 
infected with multiple species. J Microbiol Methods 2014; 
107: 189–196.
 29 Jenkins KS, Dittmer KE, Marshall JC and Tasker S. Preva-
lence and risk factor analysis of feline haemoplasma 
infection in New Zealand domestic cats using a real-time 
PCR assay. J Feline Med Surg 2013; 15: 1063–1069.
 30 Tasker S, Braddock JA, Baral R, et al. Diagnosis of feline 
haemoplasma infection in Australian cats using a real-
time PCR assay. J Feline Med Surg 2004; 6: 345–354.
 31 Hosie MJ, Addie D, Belák S, et al. Feline immunodefi-
ciency: ABCD guidelines on prevention and manage-
ment. J Feline Med Surg 2009; 11: 575–584.
 32 Tasker S, Caney SM, Day MJ, et al. Effect of chronic FIV 
infection, and efficacy of marbofloxacin treatment, on 
Mycoplasma haemofelis infection. Vet Microbiol 2006; 117: 
169–179.
 33 Berent LM, Messick JB and Cooper SK. Detection of Hae-
mobartonella felis in cats with experimentally induced 
acute and chronic infections, using a polymerase chain 
reaction assay. Am J Vet Res 1998; 59: 1215–1220.
 34 Foley JE, Harrus S, Poland A, et al. Molecular, clinical, 
and pathologic comparison of two distinct strains of Hae-
mobartonella felis in domestic cats. Am J Vet Res 1998; 59: 
1581–1588.
 35 Westfall DS, Jensen WA, Reagan WJ, et al. Inoculation of two 
genotypes of Hemobartonella felis (California and Ohio 
variants) to induce infection in cats and the response to 
treatment with azithromycin. Am J Vet Res 2001; 62: 687–691.
 36 Ghazisaeedi F, Atyabi N, Zahrai Salehi T, et al. A molecular 
study of hemotropic mycoplasmas (hemoplasmas) in cats 
in Iran. Vet Clin Pathol 2014; 43: 381–386.
 37 Lobetti RG and Tasker S. Diagnosis of feline haemo-
plasma infection using a real-time PCR assay. J S Afr Vet 
Assoc 2004; 75: 94–09.
 38 Roura X, Peters IR, Altet L, et al. Prevalence of hemotropic 
mycoplasmas in healthy and unhealthy cats and dogs in 
Spain. J Vet Diagn Invest 2010; 22: 270–274.
 39 Macieira DB, de Menezes RD, Damico CB, et al. Prevalence 
and risk factors for hemoplasmas in domestic cats natu-
rally infected with feline immunodeficiency virus and/or 
feline leukemia virus in Rio de Janeiro-Brazil. J Feline Med 
Surg 2008; 10: 120–129.
 40 Willi B, Tasker S, Boretti FS, et al. Phylogenetic analysis of 
‘Candidatus Mycoplasma turicensis’ isolates from pet cats 
in the United Kingdom, Australia, and South Africa, with 
analysis of risk factors for infection. J Clin Microbiol 2006; 
44: 4430–4435.
 41 Luria BJ, Levy JK, Lappin MR, et al. Prevalence of infec-
tious diseases in feral cats in Northern Florida. J Feline 
Med Surg 2004; 6: 287–296.
 42 Sykes JE, Drazenovich NL, Ball LM, et al. Use of conven-
tional and real-time polymerase chain reaction to deter-
mine the epidemiology of hemoplasma infections in 
anemic and nonanemic cats. J Vet Intern Med 2007; 21: 
685–693.
 43 Bergmann M, Englert T, Stuetzer B, et al. Risk factors of 
different hemoplasma species infections in cats. BMC Vet 
Res 2016; 13: 52.
 44 Aleksandar P, Vuk V, Ivan S, et al. Occurrence of Bar-
tonella henselae, FeLV and FIV infection in 60 stray cats 
from Serbia/Pojava Bartonella henselae, FeLV I FIV 
Infekcije Kod 60 Uličnih Mačaka U Srbiji. Acta Vet 2014; 
64: 378–385.
 45 Nishimura Y, Goto Y, Pang H, et al. Genetic heterogeneity 
of env gene of feline immunodeficiency virus obtained 
from multiple districts in Japan. Virus Res 1998; 57: 101–112.
 46 Kakinuma S, Motokawa K, Hohdatsu T, et al. Nucleotide 
sequence of feline immunodeficiency virus: classifica-
tion of Japanese isolates into two subtypes which are 
distinct from non-Japanese subtypes. J Virol 1995; 69: 
3639–3646.
 47 Weaver EA, Collisson EW, Slater M, et al. Phylogenetic 
analyses of Texas isolates indicate an evolving subtype of 
the clade B feline immunodeficiency viruses. J Virol 2004; 
78: 2158–2163.
 48 Steinrigl A, Ertl R, Langbein I, et al. Phylogenetic analy-
sis suggests independent introduction of feline immu-
nodeficiency virus clades A and B to Central Europe and 
identifies diverse variants of clade B. Vet Immunol Immu-
nopathol 2010; 134: 82–89.
 49 Steinrigl A and Klein D. Phylogenetic analysis of feline 
immunodeficiency virus in Central Europe: a prerequi-
site for vaccination and molecular diagnostics. J Gen Virol 
2003; 84: 1301–1307.
 50 Samman A, McMonagle EL, Logan N, et al. Phylogenetic 
characterisation of naturally occurring feline immunode-
ficiency virus in the United Kingdom. Vet Microbiol 2011; 
150: 239–247.
 51 Pinches MD, Diesel G, Helps CR, et al. An update on FIV 
and FeLV test performance using a Bayesian statistical 
approach. Vet Clin Pathol 2007; 36: 141–147.
 52 Barr MC, Pough MB, Jacobson RH and Scott FW. Compari-
son and interpretation of diagnostic tests for feline immu-
nodeficiency virus infection. J Am Vet Med Assoc 1991; 15: 
1377–1381.
 53 IDEXX Laboratories, Inc. IDEXX RealPCR Test for Feline 
Immunodeficiency Virus (FIV). http://www.idexx.com.
au/pdf/en_au/smallanimal/education/realpcr-test-for-
fiv.pdf (2011, accessed July 8, 2017).
 54 Griessmayr P, Greene CC, Egberink H, et al. Comparison 
of different new tests for feline immunodeficiency virus 
and feline leukaemia virus infection [abstract]. https://
pdfs.semanticscholar.org/5b7e/da2d72909366ff342 
f24cb4c6d3d353ce371.pdf (2002, accessed April 13, 2018).
 55 Westman ME, Malik R, Hall E, et al. Comparison of three 
feline leukaemia virus (FeLV) point-of-care antigen test 
kits using blood and saliva. Comp Immunol Microbiol Infect 
Dis 2017; 50: 88–96.
 56 Sukura A, Grohn YT, Junttila J, et al. Association between 
feline immunodeficiency virus antibodies and host char-
acteristics in Finnish cats. Acta Vet Scand 1992; 33: 325–334.
